Bosh sahifa531633 • BOM
add
Lincoln Pharmaceuticals Ltd
Yopilish kursi
477,20 ₹
Kunlik diapazon
480,45 ₹ - 484,10 ₹
Yillik diapazon
466,00 ₹ - 837,85 ₹
Bozor kapitalizatsiyasi
9,69 mlrd INR
Oʻrtacha hajm
770,00
Narx/foyda
12,09
Dividend daromadliligi
0,37%
Asosiy maydon
NSE
Bozor yangiliklari
CityNews Halifax
7 daqiqa oldin
S&P/TSX composite up nearly 150 points, U.S. stock markets also higher
0,40%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,63 mlrd | 1,33% |
Joriy xarajat | 648,09 mln | 1,64% |
Sof foyda | 199,84 mln | -24,10% |
Sof foyda marjasi | 12,23 | -25,11% |
Har bir ulushga tushum | — | — |
EBITDA | 253,58 mln | -10,65% |
Amaldagi soliq stavkasi | 30,64% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,32 mlrd | 17,48% |
Jami aktivlari | 8,55 mlrd | 9,58% |
Jami passivlari | 1,39 mlrd | -1,27% |
Umumiy kapital | 7,16 mlrd | — |
Tarqatilgan aksiyalar | 20,02 mln | — |
Narxi/balansdagi bahosi | 1,34 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 7,86% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 199,84 mln | -24,10% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products.
Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
Tashkil etilgan
1979
Xodimlar soni
1 853
